Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of Sept. 30, 2016

Portfolio Holdings for Great Point Partners

Great Point Partners holds 34 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vanda Pharmaceuticals (VNDA) 11.5 $45M 2.7M 16.64
Adamas Pharmaceuticals 10.9 $43M 2.6M 16.41
Synergy Pharmaceuticals 9.0 $35M 6.4M 5.51
Zogenix 7.1 $28M 2.4M 11.43
Foamix Pharmaceuticals 6.5 $26M 2.8M 9.26
Dermira 5.9 $23M 679k 33.82
Ignyta 5.6 $22M 3.5M 6.29
Enanta Pharmaceuticals (ENTA) 5.4 $21M 790k 26.61
Neurocrine Biosciences (NBIX) 5.1 $20M 394k 50.64
Avexis 4.0 $16M 381k 41.20
Merrimack Pharmaceuticals In 4.0 $16M 2.4M 6.35
Colucid Pharmaceuticals 3.9 $15M 400k 38.15
Bovie Medical Corporation 3.6 $14M 2.7M 5.21
Sage Therapeutics (SAGE) 3.1 $12M 265k 46.05
Connecture 2.0 $7.8M 4.1M 1.88
Aradigm 1.8 $6.9M 1.0M 6.88
Ocera Therapeutics 1.3 $5.2M 2.0M 2.64
Dbv Technologies S A (DBVT) 1.2 $4.8M 132k 36.33
Sunesis Pharmaceuticals Inc Ne 1.2 $4.6M 1.1M 4.37
Alimera Sciences 1.0 $3.9M 2.6M 1.49
BioCryst Pharmaceuticals (BCRX) 0.8 $3.2M 725k 4.41
Gw Pharmaceuticals Plc ads 0.8 $3.2M 24k 132.73
Seres Therapeutics (MCRB) 0.8 $2.9M 240k 12.29
Dipexium Pharmaceuticals 0.7 $2.6M 179k 14.50
Tenax Therapeutics 0.7 $2.6M 1.1M 2.32
PDL BioPharma 0.6 $2.2M 645k 3.35
Tetraphase Pharmaceuticals 0.4 $1.7M 452k 3.83
Catabasis Pharmaceuticals 0.4 $1.5M 250k 6.16
Mirati Therapeutics 0.4 $1.5M 228k 6.61
Inotek Pharmaceuticals 0.2 $892k 94k 9.48
Novavax 0.2 $851k 409k 2.08
Streamline Health Solutions (STRM) 0.1 $279k 152k 1.84
Ardelyx (ARDX) 0.1 $194k 15k 12.93
Ophthotech 0.0 $157k 3.4k 46.18